CLINICAL_TRIALS
trial_result
· 2016-11-18
Clinical Trial Update: Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury [Phase 2]
Summary
Phase 2 trial evaluating lovastatin to prevent radiation-induced rectal injury in prostate cancer; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Virginia Commonwealth University | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-11-18